Hydroxychloroquine to prevent SARS-CoV-2 infection among healthcare workers: early termination of a phase 3, randomised, open-label, controlled clinical trial

Hydroxychloroquine to prevent SARS-CoV-2 infection among healthcare workers: early termination of a phase 3, randomised, open-label, controlled clinical trial

Abstract Objective To assess the effectiveness and safety of hydroxychloroquine (HCQ) prophylaxis for the prevention of SARS-CoV-2 infection in healthcare workers (HCW) on duty during the COVID-19 pandemic. Results A total of 68 HCWs met the eligibility criteria were randomly allocated to receive HC...

Full description

Bibliographic Details
Main Authors: Alejandro Llanos-Cuentas, Alvaro Schwalb, Juan Luis Quintana, Brian Delfin, Fiorela Alvarez, César Ugarte-Gil, Rosio I. Guerra Gronerth, Aldo Lucchetti, Max Grogl, Eduardo Gotuzzo
Format: Article
Language:English
Published: BMC 2023-02-01
Series:BMC Research Notes
Subjects:
COVID-19
Prophylaxis
Global health
Online Access:https://doi.org/10.1186/s13104-023-06281-7

Internet

https://doi.org/10.1186/s13104-023-06281-7

Similar Items